Total Debt for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported total debt is $705.40M USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$705.40M
YoY change
+0.8%
5Y CAGR
+0.3%
Peak year (2017)
$1.04B
Latest annual
$705.40M
Total Debt history chart for Edwards Lifesciences (EW) from 1999 to 2025
Total Debt history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $705.40M | +0.8% | ||
| 2024 | $700.00M | +2.2% | ||
| 2023 | $685.10M | -0.9% | ||
| 2022 | $691.30M | +0.1% | ||
| 2021 | $690.30M | -0.7% | ||
| 2020 | $694.90M | +2.4% | ||
| 2019 | $678.80M | +14.3% | ||
| 2018 | $593.80M | -42.7% | ||
| 2017 | $1.04B | +26.0% | ||
| 2016 | $822.30M | +37.8% | ||
| 2015 | $596.90M | -0.2% | ||
| 2014 | $598.10M | +0.8% | ||
| 2013 | $593.10M | +213.3% | ||
| 2012 | $189.30M | +25.9% | ||
| 2011 | $150.40M | +259.8% | ||
| 2010 | $41.80M | -53.7% | ||
| 2009 | $90.30M | -48.5% | ||
| 2008 | $175.50M | -17.1% | ||
| 2007 | $211.70M | -10.3% | ||
| 2006 | $235.90M | -25.4% | ||
| 2005 | $316.10M | +18.3% | ||
| 2004 | $267.10M | +4.4% | ||
| 2003 | $255.80M | +4.2% | ||
| 2002 | $245.50M | -21.0% | ||
| 2001 | $310.90M | -27.4% | ||
| 2000 | $428.00M | — | ||
| 1999 | $0 | — |
Total Debt values are taken from Edwards Lifesciences's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Edwards Lifesciences (EW) most recent annual total debt stands at $705.40M (2025) – edged up 0.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Edwards Lifesciences total debt compounded at +0.3% per year, with the latest reading among the more recent periods of the dataset.
$1.04B stands as the all-time-high annual total debt, posted in 2017, against a low of $0 during 1999.
Among 8 Healthcare peers, Edwards Lifesciences (EW) ranks 9th; the peer median for total debt is $52.57B.
Edwards Lifesciences Total Debt by Year
Edwards Lifesciences Total Debt 2025: $705.40M
Edwards Lifesciences total debt in 2025 was $705.40M, edged up 0.8% from 2024.
Edwards Lifesciences Total Debt 2024: $700.00M
Edwards Lifesciences total debt in 2024 was $700.00M, edged up 2.2% from 2023.
Edwards Lifesciences Total Debt 2023: $685.10M
Edwards Lifesciences total debt in 2023 was $685.10M, edged down 0.9% below 2022.
Edwards Lifesciences Total Debt 2022: $691.30M
Edwards Lifesciences total debt in 2022 was $691.30M, edged up 0.1% from 2021.
Edwards Lifesciences Total Debt 2021: $690.30M
Edwards Lifesciences total debt in 2021 was $690.30M.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Total Debt
Companies in the same sector as Edwards Lifesciences, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's total debt?
- Latest reported total debt for Edwards Lifesciences (EW) is $705.40M (period ending December 31, 2025).
How has Edwards Lifesciences total debt changed year-over-year?
- Edwards Lifesciences (EW) total debt changed +0.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences total debt?
- Edwards Lifesciences (EW) total debt compound annual growth rate is +0.3% over the most recent 5 years available.
When did Edwards Lifesciences total debt hit its highest annual value?
- Edwards Lifesciences total debt reached its highest annual value of $1.04B in 2017.
What was Edwards Lifesciences total debt in 2024?
- Edwards Lifesciences (EW) total debt in 2024 was $700.00M.
What was Edwards Lifesciences total debt in 2025?
- Edwards Lifesciences (EW) total debt in 2025 was $705.40M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.